Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)

$7.99M USD

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Gryphon Scientific, Llc
Country	United States
Start Date	Sep 30, 2024
End Date	Sep 29, 2025
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`11167409`

Grant Description

This contract will provide support for the ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, tuberculosis (TB), hepatitis B virus (HBV).

The resulting information and associated analytical tools are critical for the rational selection and discovery of potential therapies for HIV, TB, and HBV.